New! Read the Clinical Cancer Research Melanoma Collection.
- Clinical Trials: Immunotherapy | AuthorChoiceShailender Bhatia, Natalie J. Miller, Hailing Lu, Natalie V. Longino, Dafina Ibrani, Michi M. Shinohara, David R. Byrd, Upendra Parvathaneni, Rima Kulikauskas, Jan ter Meulen, Frank J. Hsu, David M. Koelle and Paul NghiemClin Cancer Res February 15 2019 25 (4) 1185-1195; DOI:10.1158/1078-0432.CCR-18-0469
- Clinical Trials: Targeted TherapyDaniel J. George, Jean-Francois Martini, Michael Staehler, Robert J. Motzer, Ahmed Magheli, Frede Donskov, Bernard Escudier, Sherry Li, Michelle Casey, Olga Valota, Brigitte Laguerre, Allan J. Pantuck, Hardev S. Pandha, Anup Patel, Maria Lechuga and Alain RavaudClin Cancer Res February 15 2019 25 (4) 1165-1173; DOI:10.1158/1078-0432.CCR-18-1724
- Precision Medicine and ImagingSven H. Hausner, Richard J. Bold, Lina Y. Cheuy, Helen K. Chew, Megan E. Daly, Ryan A. Davis, Cameron C. Foster, Edward J. Kim and Julie L. SutcliffeClin Cancer Res February 15 2019 25 (4) 1206-1215; DOI:10.1158/1078-0432.CCR-18-2665
- Translational Cancer Mechanisms and TherapyKen Suzawa, Michael Offin, Daniel Lu, Christopher Kurzatkowski, Morana Vojnic, Roger S. Smith, Joshua K. Sabari, Huichun Tai, Marissa Mattar, Inna Khodos, Elisa de Stanchina, Charles M. Rudin, Mark G. Kris, Maria E. Arcila, William W. Lockwood, Alexander Drilon, Marc Ladanyi and Romel SomwarClin Cancer Res February 15 2019 25 (4) 1248-1260; DOI:10.1158/1078-0432.CCR-18-1640
See the Table of Contents
OnlineFirst Articles
- PD Responses to DNA DamageDeborah F Wilsker, et al.
- Tumor Immune Microenvironment Enhancement by EZH2 InhibitionMrinal M. Gounder, et al.
- ASNS Promoter Methylation Predicts Outcome in T-ALLAurore Touzart, et al.
- Challenges with Novel Clinical TrialsMichael Cecchini, et al.
Advertisement